Evoq Remedies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Evoq Remedies Ltd. on BSE

Search Inside the pdf :

Evoq Remedies Ltd.

24 Oct 2025

4.91

-4.84%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel

pdf

Evoq Remedies Ltd.

23 Oct 2025

4.91

-4.84%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel

pdf

Evoq Remedies Ltd.

23 Oct 2025

4.91

-4.84%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Patel

pdf

Evoq Remedies Ltd.

10 Oct 2025

4.91

-4.84%

Company Update

Evoq Remedies Ltd - 543500 - Integrated Filling (Finance)

BSE India

Integrated Filling (Finance)

pdf

Evoq Remedies Ltd.

10 Oct 2025

4.91

-4.84%

Result

Evoq Remedies Ltd - 543500 - Financial Result For Half Year Ended On 30Th September 2025

BSE India

Financial Result fpr half year ended on 30th September 2025

pdf

Evoq Remedies Ltd.

10 Oct 2025

4.91

-4.84%

Board Meeting

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Outcome of Board Meeting hel today i.e. 10th October 2025

pdf

Evoq Remedies Ltd.

10 Oct 2025

4.91

-4.84%

Company Update

Evoq Remedies Ltd - 543500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018

pdf

Evoq Remedies Ltd.

09 Oct 2025

4.91

-4.84%

Company Update

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Rescheduling Of Board Meeting

BSE India

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 ,inter alia, to consider and approve With reference to our earlier intimation dated 3rd October, 2025 regarding the meeting of the Board of Directors of the Company scheduled to be held on today, Thursday, 9th October, 2025 at 4:00 P.M., we wish to inform you that due to unavoidable circumstances, the said meeting has been rescheduled to Friday, 10th October, 2025 at 4:00 P. M. at the registered office of the Company i.e. A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060, inter alia, to consider and approve: 1. The Unaudited Financial Results of the Company for the Half Year ended on 30th September, 2025 along with Limited Review Report. 2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. Kindly take the same on your record and oblige us.

pdf

Evoq Remedies Ltd.

03 Oct 2025

4.91

-4.84%

Board Meeting

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Thursday, 9th October, 2025

pdf

Evoq Remedies Ltd.

30 Sep 2025, 07:47PM

4.91

-4.84%

SAST

Evoq Remedies Ltd - 543500 - Closure of Trading Window

BSE India

Intimation of the Closure of Trading Window

pdf

VOTE: Is Evoq Remedies Ltd. worth buying?

12 Votes:

Buy 91.67%

Sell 8.33%